Your browser doesn't support javascript.
loading
RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant.
Rofes, Paula; Pineda, Marta; Feliubadaló, Lídia; Menéndez, Mireia; de Cid, Rafael; Gómez, Carolina; Montes, Eva; Capellá, Gabriel; Brunet, Joan; Del Valle, Jesús; Lázaro, Conxi.
Affiliation
  • Rofes P; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
  • Pineda M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
  • Feliubadaló L; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
  • Menéndez M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
  • de Cid R; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
  • Gómez C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
  • Montes E; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
  • Capellá G; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
  • Brunet J; Genomes for Life-GCAT Lab Group, Institut Germans Trias i Pujol (IGTP) (on behalf of the GCAT project), 08916, Badalona, Spain.
  • Del Valle J; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
  • Lázaro C; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology, IDIBELL, Av. Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
Sci Rep ; 11(1): 22948, 2021 11 25.
Article in En | MEDLINE | ID: mdl-34824355
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Genetic Variation / Breast Neoplasms / Biomarkers, Tumor / Polymerase Chain Reaction / Alternative Splicing / Tumor Suppressor Proteins / Ubiquitin-Protein Ligases Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Genetic Variation / Breast Neoplasms / Biomarkers, Tumor / Polymerase Chain Reaction / Alternative Splicing / Tumor Suppressor Proteins / Ubiquitin-Protein Ligases Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom